Share buybacks · 2012–2025
Niagen Bioscience share buybacks
$251,000+$251,000 · FY2025
Niagen Bioscience (NAGE) reported $251,000 in share buybacks for fiscal 2025, +$251,000 from the year before.
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience share buybacks |url=https://companiesranked.com/en/company/niagen-bioscience/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience share buybacks. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/share-buybacksBibTeX
@misc{companiesranked-en-company-niagen-bioscience-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001386570-26-000013 · March 4, 2026
{{cite web |title=Niagen Bioscience share buybacks — 10-K (0001386570-26-000013) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/cdxc-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.